Callahan Advisors LLC Has $2,486,000 Stake in Steris Corp. (STE)
Callahan Advisors LLC lowered its stake in Steris Corp. (NYSE:STE) by 5.8% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 34,008 shares of the company’s stock after selling 2,075 shares during the period. Callahan Advisors LLC’s holdings in Steris Corp. were worth $2,486,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Janus Capital Management LLC boosted its stake in shares of Steris Corp. by 28.7% in the second quarter. Janus Capital Management LLC now owns 5,022,412 shares of the company’s stock worth $345,288,000 after buying an additional 1,120,438 shares during the period. American Century Companies Inc. boosted its stake in shares of Steris Corp. by 870.8% in the second quarter. American Century Companies Inc. now owns 1,208,491 shares of the company’s stock worth $83,084,000 after buying an additional 1,084,007 shares during the period. Villere ST Denis J & Co. LLC purchased a new stake in shares of Steris Corp. during the second quarter worth about $46,505,000. Credit Suisse AG boosted its stake in shares of Steris Corp. by 251.4% in the second quarter. Credit Suisse AG now owns 631,374 shares of the company’s stock worth $43,408,000 after buying an additional 451,699 shares during the period. Finally, Champlain Investment Partners LLC boosted its stake in shares of Steris Corp. by 92.6% in the second quarter. Champlain Investment Partners LLC now owns 898,485 shares of the company’s stock worth $61,771,000 after buying an additional 431,945 shares during the period. 91.99% of the stock is owned by institutional investors and hedge funds.
Steris Corp. (NYSE:STE) traded up 0.03% during mid-day trading on Tuesday, reaching $66.89. The company’s stock had a trading volume of 358,616 shares. The firm has a market capitalization of $5.70 billion, a PE ratio of 33.77 and a beta of 1.30. Steris Corp. has a 12 month low of $61.38 and a 12 month high of $78.77. The stock’s 50-day moving average is $67.37 and its 200-day moving average is $69.42.
Steris Corp. (NYSE:STE) last released its quarterly earnings data on Wednesday, November 2nd. The company reported $0.89 EPS for the quarter, missing the consensus estimate of $0.90 by $0.01. Steris Corp. had a net margin of 6.41% and a return on equity of 9.89%. The company earned $646.40 million during the quarter, compared to analysts’ expectations of $670.24 million. During the same period last year, the business earned $0.83 earnings per share. The company’s revenue for the quarter was up 31.9% compared to the same quarter last year. On average, equities analysts anticipate that Steris Corp. will post $3.90 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 21st. Shareholders of record on Wednesday, November 23rd will be given a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.67%. The ex-dividend date of this dividend is Monday, November 21st. Steris Corp.’s dividend payout ratio (DPR) is presently 57.14%.
COPYRIGHT VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The legal version of this report can be viewed at https://www.thecerbatgem.com/2016/11/29/callahan-advisors-llc-has-2486000-stake-in-steris-corp-ste.html.
A number of analysts recently issued reports on the company. Zacks Investment Research raised Steris Corp. from a “sell” rating to a “hold” rating in a research report on Friday, September 2nd. JMP Securities reaffirmed a “buy” rating on shares of Steris Corp. in a research note on Friday, November 4th.
In other news, Director Richard Martin Steeves sold 204,778 shares of Steris Corp. stock in a transaction dated Wednesday, September 7th. The stock was sold at an average price of $71.19, for a total transaction of $14,578,145.82. Following the sale, the director now directly owns 165,434 shares of the company’s stock, valued at $11,777,246.46. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Adrian Vincent Coward sold 15,000 shares of Steris Corp. stock in a transaction dated Wednesday, August 31st. The stock was sold at an average price of $69.00, for a total value of $1,035,000.00. The disclosure for this sale can be found here. Insiders own 2.52% of the company’s stock.
Steris Corp. Company Profile
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Receive News & Stock Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related stocks with our FREE daily email newsletter.